Male pattern hair loss: Current understanding

International Journal of Dermatology

Volumn 37, Issue 8, 1998, Pages 561-566

  Whiting, David A ^a,b,c  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b BAYLOR HEALTH CARE SYSTEM   (United States)

^c Wadley Tower ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; GENETICS; HAIR GROWTH; HAIR LOSS; HORMONAL REGULATION; MALE TYPE ALOPECIA; PATHOPHYSIOLOGY; REVIEW;

ALOPECIA; CHOLESTENONE 5 ALPHA-REDUCTASE; ENZYME INHIBITORS; FEMALE; FINASTERIDE; HAIR FOLLICLE; HUMANS; MALE; OXIDOREDUCTASES;

EID: 0031815056     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00542.x     Document Type: Review

References (50)

1. Olsen EA. Androgenetic alopecia. In: Olsen EA (ed) Disorders of Hair Growth: Diagnosis and Treatment. New York: McGraw-Hill, 1995: 257-283.
2. Whiting DA, Howsden FL. Color Atlas of Differential Diagnosis of Hair Loss. New Jersey: Canfield Publishing, 1996: 18-23.
3. Hamilton JB. Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 1942; 71: 451-480.
4. Orentreich N, Durr NP. Biology of scalp hair growth. Clin Plastic Surg 1982; 9: 197-205.
5. Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male androgenetic alopecia. J Am Acad Dermatol 1993; 28: 755-763.
6. Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 1996; 35: 899-906.
7. Montagna W, Parrakkal PF. The Structure and Function of the Skin, 3rd edn. New York: Academic Press, 1974: 172-258.
8. Sperling LC. Hair anatomy for the clinician. J Am Acad Dermatol 1991; 25: 1-17.
9. Courtois M, Loussouarn G, Hourseau S, Grollier JF. Periodicity in the growth and shedding of hair. Br J Dermatol 1996; 134: 47-54.
10. Kligman AM. The human hair cycle. J Invest Dermatol 1959; 33: 307-316.
11. Kligman AM. Pathological dynamics of human hair loss. 1. Telogen effluvium. Arch Dermatol 1961; 83: 175-198.
12. Saitoh M, Uzuka M, Sakamoto M. Human hair cycle. J Invest Dermatol 1970; 54: 63-81.
13. Ebling FJG. The biology of hair. Dermatol Clin 1987; 5(3): 467-481.
14. Paus R, Stenn KS, Link RE. Telogen skin contains an inhibitor of hair growth. Br J Dermatol 1990; 122: 777-786.
15. Orentreich N. Scalp hair replacement in man. In: Montagna W, Dobson RL, eds. Advances in Biology of the Skin. Vol. IX. Hair Growth. Oxford: Pergamon, 1969: 98-108.
16. Randall VA, Ebling FJG. Seasonal changes in human hair growth. Br J Dermatol 1991; 124: 146-157.
17. Messenger AG. The control of hair growth: an overview. J Invest Dermatol 1993; 101(Suppl 1): 4S-9S.
18. Imperato-McGinley J, Guerrero J, Gautier T, Peterson RE. Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974; 186: 1213-1215.
19. Farthing MJG, Mattei AM, Edwards CRW, et al. Relationship between plasma testosterone and dihydrotestosterone concentrations and male facial hair growth. Br J Dermatol 1982; 107: 559-564.
20. Bayne EB, Flanagan J, Azzolina B, et al. Immunolocalization of type 2 5α reductase in human hair follicles. J Invest Dermatol 1997; 108: 651 (abstr.).
21. Dallob AL, Sadick NS, Unger W, et al. The effect of Finasteride, a 5α-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab 1994; 79: 703-706.
22. Takayasu S, Adachi K. The conversion of testosterone to 17β-hydroxy-5α-androstan-3-one (dihydrotestosterone) by human hair follicles. J Clin Endocrinol Metab 1972; 34(6): 1098-1101.
23. Sawaya ME. Biochemical mechanisms regulating human hair growth. Skin Pbarmacol 1994; 7: 5-7.
24. Sawaya ME, Price VH. Different levels of 5α-reductase I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997; 109: 296-300.
25. Cotsarelis G, Sun T, Lavker RM. Label-retaining cells reside in the bulge area of pilo-sebaceous unit: implications for follicular stem cells, hair cycle and skin carcinogenesis. Cell 1990; 61: 1329-1337.
26. Harmon CS, Nevins TD. IL-alpha inhibits human hair follicle growth and hair fiber production in whole-organ cultures. Lymphokine Cytokine Res 1993; 12: 197-203.
27. Hoffmann R, Happle R. Does interleukin-1 induce hair loss? Dermatology 1995; 191: 273-275.
28. Kligman AM. The comparative histopathology of male pattern baldness and senescent baldness. Clin Dermatol 1988; 6: 108-118.
29. Norwood TT. Male pattern baldness: classification and incidence. Southern Med J 1975; 68: 1359-1370.
30. Giacometti L. The anatomy of the human scalp. In: Montagna W, ed. Advances in Biology of the Skin, Vol. 6. Oxford: Pergamon, 1965: 97-120.
31. Dawber RPR, Ebling FJG, Wojnarowska FT. Disorders of the hair. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology, 5th edn, Vol. 4. Oxford: Blackwell Scientific Publications, 1992; 2533-2577.
32. Abell E. Pathology of male pattern alopecia. Arch Dermatol 1984; 120: 1607-1608.
33. Sperling LC, Winton GB. The transverse anatomy of androgenetic alopecia. J Dermatol Surg Oncol 1990; 16: 1127-1133.
34. 2 of the scalp in male pattern baldness: a new piece to the puzzle. Plast Reconstr Surg 1996; 97(6): 1109-1117.
35. Harris H. The relation of hair growth on the body to baldness. Br J Dermatol 1947; 59: 300-309.
36. Snyder LH, Yingling HC. The application of the gene frequency method of analysis to sex-influenced factors with special reference to baldness. Human Biology 1935; 7: 608.
37. Duplechain G, White JA. Male pattern baldness. J Louisiana State Med Soc 1994; 146: 7-10.
38. Bergfeld WF. Androgenetic alopecia: an autosomal dominant disorder. Am J Med 1995; 98: 95S-98S.
39. Salamon M. Genetic factors in male pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR, eds. Biopathology of Pattern Alopecia. Basle: Karger, 1968: 39-56.
40. Hodgkins MB, Murad S, Simpson NB. A search for variation in hair follicle androgen metabolism which might be linked to male pattern baldness. Br J Dermatol 1985; 113: 794-795.
41. Northcutt RC, Island DP, Liddle GW. An explanation for the target organ unresponsiveness to testosterone in the testicular feminisation syndrome. J. Clin Endocrinol Metab 1969; 29: 422-425.
42. Trevisan M, Farinaro E, Krogh V, et al. Baldness and coronary heart disease risk factors. J Clin Epidemiol 1993; 46: 1213-1218.
43. Ford ES, Freedman DS, Byers T. Baldness and ischaemic heart disease in a national sample of men. Am J Epidemiol 1996; 143: 651-657.
44. Herrara CR, D'Agostino RB, Gerstman BB, et al. Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol 1995; 142(8): 828-833.
45. Bingham KD, Shaw DA. The metabolism of testosterone in human male scalp skin. J Endocrinol 1973; 57: 111-121.
46. Russell DW, Wiley EL, Whiting DA. Expression of steroid 50α-reductase I and II in scalp skin in normal controls and in androgenetic alopecia. In: Van Neste D, Randall VA, eds. Hair Research for the Next Millennium. Amsterdam: Elsevier, 1996: 339-340.
47. Nakanishi J, Itami S, Adachi K, et al. Expression of androgen receptor, type I and type II 5α-reductase in human dermal papilla cells. In: Van Neste D, Randall VA, eds. Hair Research for the Next Millennium. Amsterdam: Elsevier, 1996: 333-337.
48. Legro RS, Carmina E, Stanczyk FZ, et al. Alterations in androgen conjugate levels in women and men with alopecia. Fertil Steril 1994; 62: 744-750.
49. Schmidt JB, Lindmaier A, Spona J. Hormonal parameters in androgenetic hair loss in the male. Dermatologica 1991; 182: 214-217.
50. Kaufman KD. Clinical studies on the effects of oral finasteride, a type II 5α-reductase inhibitor, on scalp hair in men with male pattern baldness. In: Van Neste DJ, Randall VA, eds. Hair Research for the Next Millennium. Amsterdam: Elsevier, 1996: 363-365.